InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Kunin Jeffrey, Chief Executive Officer. Insider active across 1 companies, notably NovaBay Pharmaceuticals, Inc.. Cumulatively, 10 filings have been logged. Total volume traded: €362k. The latest transaction was filed on 3 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
€41,582101,650 shares@ €0.40910.080% mcap23.0% of flow
Common Stock
SEC:0001437749-21-028029·
Ideal exit: 30 Aug 2022 (T+270)
€41,582101,650 shares@ €0.40910.080% mcap11.5% of flow
Common Stock
SEC:0001437749-21-028029:0·
Ideal exit: 30 Aug 2022 (T+270)
€110,329262,369 shares@ €0.42050.21% mcap61.0% of flow
Common Stock
SEC:0001437749-21-027935·
Ideal exit: 29 Aug 2022 (T+270)
€110,329262,369 shares@ €0.42050.21% mcap30.5% of flow
Common Stock
SEC:0001437749-21-027935:0·
Ideal exit: 29 Aug 2022 (T+270)
€6,42114,848 shares@ €0.43250.012% mcap3.6% of flow
Common Stock
SEC:0001437749-21-027850·
Ideal exit: 28 Aug 2022 (T+270)
€6,42114,848 shares@ €0.43250.012% mcap1.8% of flow
Common Stock
SEC:0001437749-21-027850:0·
Ideal exit: 28 Aug 2022 (T+270)
€12,21930,000 shares@ €0.40730.024% mcap6.8% of flow
Common Stock
SEC:0001437749-21-027708·
Ideal exit: 27 Aug 2022 (T+270)
€12,21930,000 shares@ €0.40730.024% mcap3.4% of flow
Common Stock
SEC:0001437749-21-027708:0·
Ideal exit: 27 Aug 2022 (T+270)
€10,19925,000 shares@ €0.4080.020% mcap5.6% of flow
Common Stock
SEC:0001437749-21-027396·
Ideal exit: 19 Aug 2022 (T+270)
€10,19925,000 shares@ €0.4080.020% mcap2.8% of flow
Common Stock
SEC:0001437749-21-027396:0·
Ideal exit: 19 Aug 2022 (T+270)
10 of 10 declarations
About Kunin Jeffrey
Jeffrey Kunin is the President of DERMAdoctor, LLC and Chief Executive Officer of NovaBay Pharmaceuticals, Inc. He leads the company's operations with a focus on innovation and growth. His role is essential in ensuring the organization's success.
